The conventional clinical prognostic factors, including serum PSA levels, Gleason score and pathological stage, have been associated with PCa progression, whereas their predictive role for biochemical recurrence of PCa remains controversial (7–10). This evidence concerns the gene KLK3 and posterior cortical atrophy.